The ICD-10 code for Fetal Hydantoin Syndrome is Q86.1. In the previous ICD-9 coding system, the corresponding code was 760.72. Fetal Hydantoin Syndrome is a condition caused by exposure to the medication hydantoin during pregnancy. It can lead to various physical and developmental abnormalities in the affected fetus. Proper coding and documentation are essential for accurate diagnosis and appropriate medical management.
Fetal Hydantoin Syndrome (FHS) is a condition that occurs due to the exposure of a developing fetus to the medication hydantoin, commonly used to treat seizures. This medication includes drugs such as phenytoin and fosphenytoin. FHS can cause various physical and developmental abnormalities in the affected child.
In the International Classification of Diseases, 10th Revision (ICD-10), Fetal Hydantoin Syndrome is classified under the code Q86.0. This code specifically represents "Congenital malformation syndromes due to known exogenous causes." This classification is important as it helps healthcare professionals accurately identify and document cases of FHS.
In the previous version, the ICD-9 code for Fetal Hydantoin Syndrome was 760.72. This code fell under the category of "Other specified anomalies of the musculoskeletal system" within the ICD-9 system. It is worth noting that the ICD-9 system is no longer in use, as it has been replaced by the more detailed and comprehensive ICD-10 coding system.
By utilizing these specific ICD codes, healthcare providers can effectively communicate and track cases of Fetal Hydantoin Syndrome. These codes facilitate accurate documentation, analysis, and reporting of this condition, ultimately aiding in research, treatment, and support for individuals affected by FHS.